Carotid Plaque Length to Predict Cardiovascular Events

NCT ID: NCT05409209

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 3000 patients for suspected CAD who referred to coronary angiography from January 2017 through December 2018.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with coronary artery disease who were confirmed by coronary angiography were eligible for the study. Carotid ultrasonography was performed before coronary angiography, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Carotid plaque length

Patients underwent carotid ultrasonography and first coronary angiography simultaneously

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients≥18 years old, those who underwent carotid ultrasonography and first coronary angiography simultaneously.

Exclusion Criteria

* Patients with known coronary artery disease, previous coronary or carotid revascularization, missing carotid ultrasound or coronary angiography results.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Putuo Hospital, Shanghai University of Traditional Chinese Medicine

UNKNOWN

Sponsor Role collaborator

904th Hospital of the Joint Logistics Support Force of the PLA

OTHER

Sponsor Role collaborator

Gongli Hospital

UNKNOWN

Sponsor Role collaborator

Yueyang Hospital, Shanghai University of Traditional Chinese medicine

UNKNOWN

Sponsor Role collaborator

Changhai Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pan Li

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pan Li, PhD

Role: PRINCIPAL_INVESTIGATOR

Changhai Hospital

Jian Na, MD

Role: STUDY_DIRECTOR

Putuo Hospital

Liang Chen, MD

Role: STUDY_DIRECTOR

904th Hospital of the Joint Logistics Support Force of the PLA

Wei Zhang, MD

Role: STUDY_DIRECTOR

Gongli Hospital

Yawei Yang, MD

Role: STUDY_DIRECTOR

Yueyang Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

No. 904 Hospital of the PLA Joint Logistics Support Force

Wuxi, Jiangsu, China

Site Status

Changhai Hospital

Shanghai, Shanghai Municipality, China

Site Status

Gongli Hospital

Shanghai, Shanghai Municipality, China

Site Status

Putuo Hospital

Shanghai, Shanghai Municipality, China

Site Status

Yueyang Hospital

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CPLi-2017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cardiovascular Disease Cohort
NCT05309824 WITHDRAWN
High-Resolution CT for Heart
NCT07169201 NOT_YET_RECRUITING